1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane has been researched along with Pancreatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aruva, MR; Cardi, CA; Chakrabarti, A; Opitz, AW; Thakur, ML; Wagner, NJ; Wickstrom, E; Zhang, K | 1 |
1 other study(ies) available for 1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane and Pancreatic Neoplasms
Article | Year |
---|---|
Radiohybridization PET imaging of KRAS G12D mRNA expression in human pancreas cancer xenografts with [(64)Cu]DO3A-peptide nucleic acid-peptide nanoparticles.
Topics: Animals; Copper Radioisotopes; Female; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Mice; Nanoparticles; Neoplasm Transplantation; Pancreatic Neoplasms; Peptide Nucleic Acids; Peptides; Positron-Emission Tomography; Proto-Oncogene Proteins p21(ras); RNA, Messenger | 2007 |